AKTX news

Latest 1 stories · newest Nov 12, 2026

AKTX
Akari initiates GLP toxicology for ADC AKTX-101

Akari Therapeutics started GLP studies for AKTX-101 and secured $5.7M in cash, advancing its novel PH1 payload towards clinical trials.

Earnings|Guidance|M&A|Buyback|Dividend|Leadership|Restructuring|Regulatory|Legal|Cyber|Offering|Bankruptcy|Other Nov 12, 2026 sentiment +0.30 SEC filing ↗
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same AKTX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/AKTX/newsSTART FREE